COVID-19 PCR Test

At Unique Biosciences^TM, we are committed to advancing human health through accurate, accessible, and innovative diagnostic solutions. In response to the global COVID-19 pandemic, we are using a reliable testing approach designed by a SalivaDirect^TM to support healthcare providers, businesses, and communities in detecting and monitoring SARS-CoV-2, the virus that causes COVID-19.

Why Our Test Matters

• High Accuracy – Built on advanced qPCR technology, our test is designed to deliver highly sensitive and accurate results, minimizing false positives and false negatives.
• Rapid Results – Timely detection is critical for both patient care and public health. Our solutions provide results within 24 hours, helping guide fast decision-making.
• Non-Invasive Sample Collection – Our research emphasizes patient comfort. We use saliva-based noninvasive methods, eliminating the discomfort often associated with blood or swab-based testing.
• Scalable for Communities – From clinical settings to workplace screenings, our testing platform is adaptable to meet the needs of mass communities.

Our Commitment

COVID-19 highlighted the importance of rapid innovation in biotechnology. At Unique Biosciences^TM, we are proud to contribute diagnostic solutions that not only support pandemic response efforts but also lay the groundwork for future preparedness against emerging infectious diseases.

Together, we continue to build healthier, more resilient communities through science and innovation.